These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 33713575)

  • 1. Interleukin-36α suppresses growth of non-small cell lung cancer in vitro by reducing angiogenesis.
    Xie X; Hu H; He J; Liu Y; Guo F; Luo F; Jiang M; Wang L
    FEBS Open Bio; 2021 May; 11(5):1353-1363. PubMed ID: 33713575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-37 suppresses tumor growth through inhibition of angiogenesis in non-small cell lung cancer.
    Ge G; Wang A; Yang J; Chen Y; Yang J; Li Y; Xue Y
    J Exp Clin Cancer Res; 2016 Jan; 35():13. PubMed ID: 26791086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant p53 expression correlates with expression of vascular endothelial growth factor mRNA and interleukin-8 mRNA and neoangiogenesis in non-small-cell lung cancer.
    Yuan A; Yu CJ; Luh KT; Kuo SH; Lee YC; Yang PC
    J Clin Oncol; 2002 Feb; 20(4):900-10. PubMed ID: 11844810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of S100A13 protein is associated with tumor angiogenesis and poor survival in patients with early-stage non-small cell lung cancer.
    Miao S; Qiu T; Zhao Y; Wang H; Sun X; Wang Y; Xuan Y; Qin Y; Jiao W
    Thorac Cancer; 2018 Sep; 9(9):1136-1144. PubMed ID: 30047626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased expression of interleukin-36α correlates with poor prognosis in hepatocellular carcinoma.
    Pan QZ; Pan K; Zhao JJ; Chen JG; Li JJ; Lv L; Wang DD; Zheng HX; Jiang SS; Zhang XF; Xia JC
    Cancer Immunol Immunother; 2013 Nov; 62(11):1675-85. PubMed ID: 24061617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-8 in non-small cell lung carcinoma: relation with angiogenic pattern and p53 alterations.
    Boldrini L; Gisfredi S; Ursino S; Lucchi M; Mussi A; Basolo F; Pingitore R; Fontanini G
    Lung Cancer; 2005 Dec; 50(3):309-17. PubMed ID: 16125276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-36α inhibits colorectal cancer metastasis by enhancing the infiltration and activity of CD8
    Wei X; Yao Y; Wang X; Sun J; Zhao W; Qiu L; Zhai W; Qi Y; Gao Y; Wu Y
    Int Immunopharmacol; 2021 Nov; 100():108152. PubMed ID: 34555640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-20 is epigenetically regulated in NSCLC and down regulates the expression of VEGF.
    Baird AM; Gray SG; O'Byrne KJ
    Eur J Cancer; 2011 Aug; 47(12):1908-18. PubMed ID: 21565488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AEG-1 mRNA expression in non-small cell lung cancer is associated with increased tumor angiogenesis.
    Ma Z; Chen Y; Dong S; Xu X; Liu J; Song P; Yu C; Dai L
    Pathol Res Pract; 2017 Oct; 213(10):1257-1263. PubMed ID: 28941723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of CD82/KAI1 and HIF-1α in non-small cell lung cancer and their relationship to vasculogenic mimicry].
    Wu S; Cheng Z; Yu L; Song W; Tao Y
    Zhongguo Fei Ai Za Zhi; 2011 Dec; 14(12):918-25. PubMed ID: 22152691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer.
    Chen JJ; Yao PL; Yuan A; Hong TM; Shun CT; Kuo ML; Lee YC; Yang PC
    Clin Cancer Res; 2003 Feb; 9(2):729-37. PubMed ID: 12576442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-141 and miR-200c as markers of overall survival in early stage non-small cell lung cancer adenocarcinoma.
    Tejero R; Navarro A; Campayo M; Viñolas N; Marrades RM; Cordeiro A; Ruíz-Martínez M; Santasusagna S; Molins L; Ramirez J; Monzó M
    PLoS One; 2014; 9(7):e101899. PubMed ID: 25003366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-35 Expression in Non-Small Cell Lung Cancer is Associated with Tumor Progression.
    Sun M; Zheng X; Meng Q; Dong Y; Zhang G; Rao D; An X; Yang Z; Pan L; Zhang S
    Cell Physiol Biochem; 2018; 51(4):1839-1851. PubMed ID: 30504722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NDRG1/Cap43/Drg-1 may predict tumor angiogenesis and poor outcome in patients with lung cancer.
    Azuma K; Kawahara A; Hattori S; Taira T; Tsurutani J; Watari K; Shibata T; Murakami Y; Takamori S; Ono M; Izumi H; Kage M; Yanagawa T; Nakagawa K; Hoshino T; Kuwano M
    J Thorac Oncol; 2012 May; 7(5):779-89. PubMed ID: 22481237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FUS-stabilized USP35 promotes growth, invasion and angiogenesis in NSCLC through deubiquitinating VEGFA.
    Li W; Li J; Li W; Li J; Zheng W; Cheng J; Zhang X; Yang B; Dong J; Sun X
    Gen Physiol Biophys; 2024 Jul; 43(4):301-312. PubMed ID: 38953570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor expression in stage I non-small cell lung cancer correlates with neoangiogenesis and a poor prognosis.
    Han H; Silverman JF; Santucci TS; Macherey RS; d'Amato TA; Tung MY; Weyant RJ; Landreneau RJ
    Ann Surg Oncol; 2001; 8(1):72-9. PubMed ID: 11206229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinoblastoma binding protein 2 (RBP2) promotes HIF-1α-VEGF-induced angiogenesis of non-small cell lung cancer via the Akt pathway.
    Qi L; Zhu F; Li SH; Si LB; Hu LK; Tian H
    PLoS One; 2014; 9(8):e106032. PubMed ID: 25162518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-36α suppresses proliferation of ovarian cancer cells.
    Chang L; Guo R; Yuan Z
    Tumour Biol; 2017 Jun; 39(6):1010428317706918. PubMed ID: 28621240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of Interleukin-36s in cancers: A systematic review and meta-analysis.
    Zhang R; Jiang M; Huang M; Yang J; Liu Q; Zhao Z; Bai Y; He T; Zhang D; Zhang M
    Cytokine; 2023 Dec; 172():156397. PubMed ID: 37922622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.